Cardiac epinephrine synthesis and ischemia-induced myocardial epinephrine release

Yosuke Kuroko, Toji Yamazaki, Noriyuki Tokunaga, Tsuyoshi Akiyama, Hirotoshi Kitagawa, Kozo Ishino, Shunji Sano, Hidezo Mori

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: Phenylethanolamine-N-methyltransferase (PNMT), the enzyme that synthesizes epinephrine (EPI) from norepinephrine (NE) in the adrenal gland, is present in extra-adrenal tissues including heart. Ischemia evokes an excessive NE accumulation in the myocardial interstitial spaces. Therefore, cardiac PNMT activity with high NE levels may contribute to cardiac EPI synthesis and release evoked by ischemia. Methods: We measured dialysate EPI levels in the left ventricle of anesthetized rabbits using a cardiac microdialysis technique. The dialysate EPI level served as an index of the myocardial interstitial EPI level. Locally administered NE-induced dialysate EPI responses were measured. The left circumflex coronary artery was occluded for 60 min and the dialysate EPI and NE levels in the ischemic region were measured. Coronary occlusion-induced EPI responses were compared with and without administration of a PNMT inhibitor (SKF29661) in the presence and absence of desipramine (catecholamine transport blocker). Results: Local administration of NE (250, 2500 ng/ml) increased the EPI levels to 734 ± 125 and 2088 ± 367 pg/ml respectively. These increases in dialysate EPI were suppressed by the PNMT inhibitor. Acute myocardial ischemia significantly increased the EPI levels to 3607 ± 1069 pg/ml in the ischemic region, and these were suppressed by the PNMT inhibitor (1417 ± 581 pg/ml). The pretreatment with desipramine suppressed ischemia-induced EPI release, which did not differ with (725 ± 155 pg/ml) and without administration of a PNMT inhibitor (743 ± 172 pg/ml). Conclusion: The cardiac PNMT in the left ventricle is capable of synthesizing EPI with markedly elevated NE levels in the myocardial interstitial space.

Original languageEnglish
Pages (from-to)438-444
Number of pages7
JournalCardiovascular Research
Volume74
Issue number3
DOIs
Publication statusPublished - Jun 1 2007

Fingerprint

Epinephrine
Myocardial Ischemia
Phenylethanolamine N-Methyltransferase
Norepinephrine
Dialysis Solutions
Desipramine
Ischemia
Heart Ventricles
Coronary Occlusion
Microdialysis
Adrenal Glands
Catecholamines
Coronary Vessels
Rabbits

Keywords

  • Autonomic nervous system
  • Interstitial space
  • Ischemia
  • Neurotransmitters
  • Reperfusion

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Kuroko, Y., Yamazaki, T., Tokunaga, N., Akiyama, T., Kitagawa, H., Ishino, K., ... Mori, H. (2007). Cardiac epinephrine synthesis and ischemia-induced myocardial epinephrine release. Cardiovascular Research, 74(3), 438-444. https://doi.org/10.1016/j.cardiores.2007.02.018

Cardiac epinephrine synthesis and ischemia-induced myocardial epinephrine release. / Kuroko, Yosuke; Yamazaki, Toji; Tokunaga, Noriyuki; Akiyama, Tsuyoshi; Kitagawa, Hirotoshi; Ishino, Kozo; Sano, Shunji; Mori, Hidezo.

In: Cardiovascular Research, Vol. 74, No. 3, 01.06.2007, p. 438-444.

Research output: Contribution to journalArticle

Kuroko, Y, Yamazaki, T, Tokunaga, N, Akiyama, T, Kitagawa, H, Ishino, K, Sano, S & Mori, H 2007, 'Cardiac epinephrine synthesis and ischemia-induced myocardial epinephrine release', Cardiovascular Research, vol. 74, no. 3, pp. 438-444. https://doi.org/10.1016/j.cardiores.2007.02.018
Kuroko, Yosuke ; Yamazaki, Toji ; Tokunaga, Noriyuki ; Akiyama, Tsuyoshi ; Kitagawa, Hirotoshi ; Ishino, Kozo ; Sano, Shunji ; Mori, Hidezo. / Cardiac epinephrine synthesis and ischemia-induced myocardial epinephrine release. In: Cardiovascular Research. 2007 ; Vol. 74, No. 3. pp. 438-444.
@article{3a22fb6c31eb4e719f033418b6cac913,
title = "Cardiac epinephrine synthesis and ischemia-induced myocardial epinephrine release",
abstract = "Objective: Phenylethanolamine-N-methyltransferase (PNMT), the enzyme that synthesizes epinephrine (EPI) from norepinephrine (NE) in the adrenal gland, is present in extra-adrenal tissues including heart. Ischemia evokes an excessive NE accumulation in the myocardial interstitial spaces. Therefore, cardiac PNMT activity with high NE levels may contribute to cardiac EPI synthesis and release evoked by ischemia. Methods: We measured dialysate EPI levels in the left ventricle of anesthetized rabbits using a cardiac microdialysis technique. The dialysate EPI level served as an index of the myocardial interstitial EPI level. Locally administered NE-induced dialysate EPI responses were measured. The left circumflex coronary artery was occluded for 60 min and the dialysate EPI and NE levels in the ischemic region were measured. Coronary occlusion-induced EPI responses were compared with and without administration of a PNMT inhibitor (SKF29661) in the presence and absence of desipramine (catecholamine transport blocker). Results: Local administration of NE (250, 2500 ng/ml) increased the EPI levels to 734 ± 125 and 2088 ± 367 pg/ml respectively. These increases in dialysate EPI were suppressed by the PNMT inhibitor. Acute myocardial ischemia significantly increased the EPI levels to 3607 ± 1069 pg/ml in the ischemic region, and these were suppressed by the PNMT inhibitor (1417 ± 581 pg/ml). The pretreatment with desipramine suppressed ischemia-induced EPI release, which did not differ with (725 ± 155 pg/ml) and without administration of a PNMT inhibitor (743 ± 172 pg/ml). Conclusion: The cardiac PNMT in the left ventricle is capable of synthesizing EPI with markedly elevated NE levels in the myocardial interstitial space.",
keywords = "Autonomic nervous system, Interstitial space, Ischemia, Neurotransmitters, Reperfusion",
author = "Yosuke Kuroko and Toji Yamazaki and Noriyuki Tokunaga and Tsuyoshi Akiyama and Hirotoshi Kitagawa and Kozo Ishino and Shunji Sano and Hidezo Mori",
year = "2007",
month = "6",
day = "1",
doi = "10.1016/j.cardiores.2007.02.018",
language = "English",
volume = "74",
pages = "438--444",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Cardiac epinephrine synthesis and ischemia-induced myocardial epinephrine release

AU - Kuroko, Yosuke

AU - Yamazaki, Toji

AU - Tokunaga, Noriyuki

AU - Akiyama, Tsuyoshi

AU - Kitagawa, Hirotoshi

AU - Ishino, Kozo

AU - Sano, Shunji

AU - Mori, Hidezo

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Objective: Phenylethanolamine-N-methyltransferase (PNMT), the enzyme that synthesizes epinephrine (EPI) from norepinephrine (NE) in the adrenal gland, is present in extra-adrenal tissues including heart. Ischemia evokes an excessive NE accumulation in the myocardial interstitial spaces. Therefore, cardiac PNMT activity with high NE levels may contribute to cardiac EPI synthesis and release evoked by ischemia. Methods: We measured dialysate EPI levels in the left ventricle of anesthetized rabbits using a cardiac microdialysis technique. The dialysate EPI level served as an index of the myocardial interstitial EPI level. Locally administered NE-induced dialysate EPI responses were measured. The left circumflex coronary artery was occluded for 60 min and the dialysate EPI and NE levels in the ischemic region were measured. Coronary occlusion-induced EPI responses were compared with and without administration of a PNMT inhibitor (SKF29661) in the presence and absence of desipramine (catecholamine transport blocker). Results: Local administration of NE (250, 2500 ng/ml) increased the EPI levels to 734 ± 125 and 2088 ± 367 pg/ml respectively. These increases in dialysate EPI were suppressed by the PNMT inhibitor. Acute myocardial ischemia significantly increased the EPI levels to 3607 ± 1069 pg/ml in the ischemic region, and these were suppressed by the PNMT inhibitor (1417 ± 581 pg/ml). The pretreatment with desipramine suppressed ischemia-induced EPI release, which did not differ with (725 ± 155 pg/ml) and without administration of a PNMT inhibitor (743 ± 172 pg/ml). Conclusion: The cardiac PNMT in the left ventricle is capable of synthesizing EPI with markedly elevated NE levels in the myocardial interstitial space.

AB - Objective: Phenylethanolamine-N-methyltransferase (PNMT), the enzyme that synthesizes epinephrine (EPI) from norepinephrine (NE) in the adrenal gland, is present in extra-adrenal tissues including heart. Ischemia evokes an excessive NE accumulation in the myocardial interstitial spaces. Therefore, cardiac PNMT activity with high NE levels may contribute to cardiac EPI synthesis and release evoked by ischemia. Methods: We measured dialysate EPI levels in the left ventricle of anesthetized rabbits using a cardiac microdialysis technique. The dialysate EPI level served as an index of the myocardial interstitial EPI level. Locally administered NE-induced dialysate EPI responses were measured. The left circumflex coronary artery was occluded for 60 min and the dialysate EPI and NE levels in the ischemic region were measured. Coronary occlusion-induced EPI responses were compared with and without administration of a PNMT inhibitor (SKF29661) in the presence and absence of desipramine (catecholamine transport blocker). Results: Local administration of NE (250, 2500 ng/ml) increased the EPI levels to 734 ± 125 and 2088 ± 367 pg/ml respectively. These increases in dialysate EPI were suppressed by the PNMT inhibitor. Acute myocardial ischemia significantly increased the EPI levels to 3607 ± 1069 pg/ml in the ischemic region, and these were suppressed by the PNMT inhibitor (1417 ± 581 pg/ml). The pretreatment with desipramine suppressed ischemia-induced EPI release, which did not differ with (725 ± 155 pg/ml) and without administration of a PNMT inhibitor (743 ± 172 pg/ml). Conclusion: The cardiac PNMT in the left ventricle is capable of synthesizing EPI with markedly elevated NE levels in the myocardial interstitial space.

KW - Autonomic nervous system

KW - Interstitial space

KW - Ischemia

KW - Neurotransmitters

KW - Reperfusion

UR - http://www.scopus.com/inward/record.url?scp=34247874763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247874763&partnerID=8YFLogxK

U2 - 10.1016/j.cardiores.2007.02.018

DO - 10.1016/j.cardiores.2007.02.018

M3 - Article

C2 - 17448453

AN - SCOPUS:34247874763

VL - 74

SP - 438

EP - 444

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 3

ER -